Trials / Completed
CompletedNCT02107404
Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer
Randomized, Open-label, Parallel-group, Multi-centre Phase II Clinical Trial With Active Cellular Immunotherapy DCVAC/PCa in Patients With Localized Prostate Cancer After Primary Radical Prostatectomy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- SOTIO a.s. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether DCVAC/PCa added after radical primary prostatectomy can improve PSA doubling times for patients with localized Prostate Cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Dendritic Cells DCVAC/PCa | DCVAC/PCa Experimental therapy |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2015-06-01
- Completion
- 2017-05-22
- First posted
- 2014-04-08
- Last updated
- 2017-05-24
Locations
11 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT02107404. Inclusion in this directory is not an endorsement.